Cargando…
Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.
Interferon alpha (IFN-alpha) has a documented activity against malignant melanoma with a response rate of only approximately 20%. It would therefore be of considerable importance if patients likely to respond could be identified. The degree of mononuclear cell infiltration in primary tumours has bee...
Autores principales: | Håkansson, A., Gustafsson, B., Krysander, L., Håkansson, L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074699/ https://www.ncbi.nlm.nih.gov/pubmed/8845294 |
Ejemplares similares
-
Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes
por: Håkansson, A, et al.
Publicado: (2001) -
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
por: Bernsen, M R, et al.
Publicado: (2003) -
A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma.
por: Ravaud, A., et al.
Publicado: (1995) -
Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma.
por: Hersey, P., et al.
Publicado: (1985) -
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
por: Sarnaik, Amod A., et al.
Publicado: (2021)